From a suite of swank, sun-drenched offices above an art gallery in Studio Park, hedge fund manager Eiad Asbahi has been waging a proxy war for control of a little-known pharmaceutical company, whose …
Already an INSIDER? Sign in.
Don’t sell Eiad Asbahi short
